12:00 AM
 | 
Jun 11, 2012
 |  BC Week In Review  |  Company News  |  Other News

Emergent BioSolutions infectious news

HHS's Biomedical Advanced Research and Development Authority (BARDA) awarded Emergent additional funding up to $8.4 million under a 2007 contract to develop and supply its BioThrax anthrax vaccine. In exchange, Emergent will conduct a...

Read the full 159 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >